Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 8.74% vs -15.83% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 35.76% vs 5.20% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 28.33% vs -3.60% in Mar 2024
Compare Balance Sheet Results of Oxygenta Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
36.98
11.88
25.10
211.28%
Share Warrants & Outstandings
Total Reserve
-62.01
24.76
-86.77
-350.44%
Shareholder's Funds
-25.02
38.00
-63.02
-165.84%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
21.52
5.29
16.23
306.81%
Secured Loans
2.63
5.23
-2.60
-49.71%
Unsecured Loans
18.89
0.06
18.83
31,383.33%
Deferred Tax Assets / Liabilities
-10.80
0.77
-11.57
-1,502.60%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.08
0.48
0.60
125.00%
Total Non-Current Liabilities
11.80
6.53
5.27
80.70%
Current Liabilities
Trade Payables
29.79
15.25
14.54
95.34%
Other Current Liabilities
15.11
3.33
11.78
353.75%
Short Term Borrowings
40.71
0.34
40.37
11,873.53%
Short Term Provisions
0.23
1.54
-1.31
-85.06%
Total Current Liabilities
85.85
20.46
65.39
319.60%
Total Liabilities
72.62
65.00
7.62
11.72%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
61.50
28.26
33.24
117.62%
Less: Accumulated Depreciation
21.87
7.70
14.17
184.03%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
39.63
20.56
19.07
92.75%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.23
0.00
0.23
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
3.00
-2.95
-98.33%
Long Term Loans & Advances
0.68
2.05
-1.37
-66.83%
Other Non Current Assets
1.08
1.28
-0.20
-15.62%
Total Non-Current Assets
41.68
26.89
14.79
55.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
20.51
10.42
10.09
96.83%
Sundry Debtors
5.10
16.68
-11.58
-69.42%
Cash and Bank
0.12
1.56
-1.44
-92.31%
Other Current Assets
4.58
0.09
4.49
4,988.89%
Short Term Loans and Advances
0.63
9.36
-8.73
-93.27%
Total Current Assets
30.94
38.10
-7.16
-18.79%
Net Current Assets (Including Current Investments)
-54.90
17.64
-72.54
-411.22%
Total Current Assets Excluding Current Investments
30.94
38.10
-7.16
-18.79%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
72.62
65.00
7.62
11.72%
Contingent Liabilities
2.91
0.00
2.91
0.00%
Total Debt
62.23
5.62
56.61
1,007.30%
Book Value per share (adjusted)
-6.77
30.84
-37.61
-121.95%
Annual - Borrowings
Borrowings 62.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.74% vs -15.83% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 39.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 35.76% vs 5.20% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 30.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.33% vs -3.60% in Mar 2024






